The University of Chicago Medicine Comprehensive Cancer Center has partnered with the Energy Department to harness the technology of the department's Argonne National Laboratory toward the development of treatments for drug-resistant cancers.
The Latest
Researchers from Chicago-based Northwestern Medicine Canning Thoracic Institute found that the COVID-19 virus triggers the development of a unique immune cell with anti-cancer properties, it said in a Nov. 15 system news release.
Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer.
When diagnosed with prostate cancer, men with limited life expectancy are being overtreated, according to a study published Nov. 11 in JAMA Internal Medicine.
Among the many factors at play in overcoming cancer care gaps in the U.S., increased screening and access to care are top of mind. However, cancer trial participation is also crucial.
An FDA advisory panel endorsed a minimally invasive breast cancer surgery alternative at a Nov. 7 meeting.
Research and innovation have steadily driven advancements in breast cancer screening since Congress enacted the Mammography Quality Standards Act in 1992.
Houston-based University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation. Research at the institute will focus on immunology and cell engineering with the purpose of creating new treatments for cancer and autoimmune…
Altamonte Springs, Fla.-based AdventHealth has launched a pilot program designed to harness AI to assess a patient's risk of developing breast cancer.
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial.